renal-insufficiency

Documents about renal-insufficiency

• Kidney Precision Medicine Project#905549ClinicalTrials.gov
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients#844628ClinicalTrials.gov
• SP2086 Pharmacokinetic Study in Renal Insufficiency Patients#908742ClinicalTrials.gov
• Study of Copanlisib in Hepatic or Renal Impairment#860531ClinicalTrials.gov
• Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease#849475ClinicalTrials.gov
• Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)#888307ClinicalTrials.gov
• Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure#864139ClinicalTrials.gov
• Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly#918036ClinicalTrials.gov
• Improving Evidence-Based Primary Care for Chronic Kidney Disease#143757ClinicalTrials.gov
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency#879016ClinicalTrials.gov
• Venous Congestion and Acute Renal Failure in Cardiac Surgery Postoperative#842416ClinicalTrials.gov
• Renal replacement therapy in type 2 severe cardiorenal syndrome: a randomized controlled trial#202630HAL (France)
• Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine#840676ClinicalTrials.gov
• Local and Systemic Inflammatory Bone Alterations Related to Dental Implant Survival.#994861ClinicalTrials.gov
• Prognosis of Patients With Acute Coronary Syndrome Complicated With Renal Insufficiency(PACS-RI)#800452ClinicalTrials.gov
• Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients#825795ClinicalTrials.gov
• Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)#896291ClinicalTrials.gov
• TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment#885821ClinicalTrials.gov
• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™#181694ClinicalTrials.gov
• Maintenance Treatment of Renal Anemia in Dialysis Subjects#803861ClinicalTrials.gov
• Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease#296819Gestión del Repositorio Documental de la Universidad de Salamanca
• Renal Safety Evaluation After Dotarem®-Enhanced MRI#861985ClinicalTrials.gov
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects#879739ClinicalTrials.gov
• Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE)#910710ClinicalTrials.gov
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)#825346ClinicalTrials.gov
• Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease#859501ClinicalTrials.gov
• Catheter System Feasibility Clinical Trial#801980ClinicalTrials.gov
• A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants#879295ClinicalTrials.gov
• Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease#18728ClinicalTrials.gov
• A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects#982169ClinicalTrials.gov
• Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation#831369ClinicalTrials.gov
• Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function#840005ClinicalTrials.gov
• Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency#801628ClinicalTrials.gov
• The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insufficiency#812453ClinicalTrials.gov
• Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency#834313ClinicalTrials.gov
• Renal Involvement in Hospitalized Children With COVID-19#916276ClinicalTrials.gov
• Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study#325254ClinicalTrials.gov
• De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction#1007543ClinicalTrials.gov
• Finerenona y trasplante renal, ¿una nueva frontera terapéutica?#353709Gestión del Repositorio Documental de la Universidad de Salamanca
• Multiple Intervention and AUdit in Renal Diseases to Optimize Care#268109ClinicalTrials.gov
• Natural Course for Renal Function After Heart Transplantation#1009139ClinicalTrials.gov
• Tobramycin Administered at the Beginning of Dialysis#969233ClinicalTrials.gov
• Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects#1010385ClinicalTrials.gov
• The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects#812559ClinicalTrials.gov
• Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function#982288ClinicalTrials.gov
• Chronic Kidney Disease in Pakistani Population#894769ClinicalTrials.gov
• Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function#868886ClinicalTrials.gov
• HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis#870916ClinicalTrials.gov
• Determination In-vivo KUF for Diacap Pro Hemodialyser#832562ClinicalTrials.gov
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency#911377ClinicalTrials.gov